BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16807803)

  • 1. Do myoepithelial cells hold the key for breast tumor progression?
    Polyak K; Hu M
    J Mammary Gland Biol Neoplasia; 2005 Jul; 10(3):231-47. PubMed ID: 16807803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.
    Barsky SH; Karlin NJ
    J Mammary Gland Biol Neoplasia; 2005 Jul; 10(3):249-60. PubMed ID: 16807804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia.
    Gudjonsson T; Adriance MC; Sternlicht MD; Petersen OW; Bissell MJ
    J Mammary Gland Biol Neoplasia; 2005 Jul; 10(3):261-72. PubMed ID: 16807805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of the tumor microenvironment in breast cancer.
    Allinen M; Beroukhim R; Cai L; Brennan C; Lahti-Domenici J; Huang H; Porter D; Hu M; Chin L; Richardson A; Schnitt S; Sellers WR; Polyak K
    Cancer Cell; 2004 Jul; 6(1):17-32. PubMed ID: 15261139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
    Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
    J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
    Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
    BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF-2 is overexpressed in myoepithelial cells of carcinoma ex-pleomorphic adenoma in situ structures.
    Martinez EF; Demasi AP; Miguita L; Altemani A; Araújo NS; Araújo VC
    Oncol Rep; 2010 Jul; 24(1):155-60. PubMed ID: 20514456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
    Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
    Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.
    Man YG; Tai L; Barner R; Vang R; Saenger JS; Shekitka KM; Bratthauer GL; Wheeler DT; Liang CY; Vinh TN; Strauss BL
    Breast Cancer Res; 2003; 5(6):R231-41. PubMed ID: 14580259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of myoepithelial cells in breast tumor progression.
    Pandey PR; Saidou J; Watabe K
    Front Biosci (Landmark Ed); 2010 Jan; 15(1):226-36. PubMed ID: 20036817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
    Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
    Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade carcinomas of the breast showing patterns of mixed ductal and myoepithelial differentiation (including myoepithelial cell-rich carcinoma of the breast).
    Coyne JD; Dervan PA; Barr L
    Histopathology; 2004 Jun; 44(6):580-4. PubMed ID: 15186273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness.
    Xu Z; Wang W; Deng CX; Man YG
    Int J Biol Sci; 2009; 5(1):82-96. PubMed ID: 19173015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell.
    Barsky SH; Karlin NJ
    Nat Clin Pract Oncol; 2006 Mar; 3(3):138-51. PubMed ID: 16520804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.
    Novitskaya V; Romanska H; Dawoud M; Jones JL; Berditchevski F
    Cancer Res; 2010 Jun; 70(11):4698-708. PubMed ID: 20501858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
    Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
    J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.
    Lebret SC; Newgreen DF; Waltham MC; Price JT; Thompson EW; Ackland ML
    In Vitro Cell Dev Biol Anim; 2006; 42(10):298-307. PubMed ID: 17316063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study.
    Damiani S; Ludvikova M; Tomasic G; Bianchi S; Gown AM; Eusebi V
    Virchows Arch; 1999 Mar; 434(3):227-34. PubMed ID: 10190302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.